NEW YORK (GenomeWeb) – WuXi AppTec announced today that its laboratory testing division has signed on as the exclusive distributor of AutoGenomics' molecular diagnostic systems and related products in China.
Under the terms of the deal, WuXi's lab division will manufacture, register, and distribute AutoGenomics' Infiniti line of molecular diagnostic systems, as well as related reagents and consumables for the Chinese market. In exchange, WuXi will license the rights to manufacture and assemble the systems.
The Infiniti system is a multiplexed microarray platform for the detection of genetic markers. AutoGenomics currently offers 65 tests for the system, including US Food and Drug Administration-approved assays for Factor II, Factor V Leiden, Factor II-V Leiden, warfarin response, and CYP2C19 variants.
The companies have also agreed to collaborate on the development and commercialization of new diagnostic technologies and products that are specifically designed for Chinese patients.
Additional terms of the deal were not disclosed.